Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1463 of 5804
-
New drug TOS-358 targets Hard-to-Treat breast cancer in early trial
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and efficacy of TOS-358 in women with HR+ HER2- metastatic breast cancer whose tumors have a mutation in PIK3CA and who meet all other study enrollment criteria. The main questions it aims to answer are: 1. Phase 1a: what…
Phase: PHASE1 • Sponsor: Totus Medicines • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New pill HEC585 aims to slow lung scarring in rare disease
Disease control Recruiting nowThe main goal of this phase llb study is to compare the efficacy and safety of two doses of HEC585 tablets with placebo which is a look-alike substance that contains no active drug in patients with progressive fibrosing interstitial lung diseases. This study is divided into two s…
Phase: PHASE2 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Cancer drug repurposed to fight deadly lung scarring
Disease control OngoingThe purpose of this study is to determine the safety and preliminary efficacy of atezolizumab, an immune checkpoint inhibitor approved for the treatment of various cancers, in patients with idiopathic pulmonary fibrosis (IPF).
Phase: PHASE1 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Can a 6-Week video therapy ease body image pain for head and neck cancer survivors?
Symptom relief Recruiting nowIn this multi-center randomized clinical trial, head and neck cancer (HNC) survivors with clinically significant body image distress (BID) (N=180) will be randomized to BRIGHT (a brief video tele-cognitive behavioral therapy intervention) or Attention Control (AC, a manualized te…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Can a cancer vaccine plus hormone drugs slow prostate cancer?
Disease control OngoingThis study is designed to test the hypothesis that using Sipuleucel-T (Provenge) in combination with new hormonal agents (NHA) (abiraterone, enzalutamide, apalutamide) for the treatment of participants with asymptomatic metastatic castration resistant prostate cancer (mCRPC) and …
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New drug shows promise for diabetic kidney damage in Mid-Stage trial
Disease control CompletedTo evaluate the efficacy and safety of CU01-1001 administered for 24 weeks in type 2 diabetic nephropathy patients with albuminuria.
Phase: PHASE2 • Sponsor: Curacle Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New seizure drug shows promise in late-stage trial
Disease control Recruiting nowThis is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of XEN1101 administered as adjunctive treatment in primary generalized tonic-clonic seizures (PGTCS).
Phase: PHASE3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Poop pills from superdonors could tame colitis
Disease control Recruiting nowIn the last decades fecal microbiota transplantation (FMT) has been established as a highly effective option in the treatment of recurrent Clostridioides difficile infection (rCDI), with a success rate of nearly 90%. For this reason, it is recommended by international guidelines …
Phase: PHASE1, PHASE2 • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug combo aims to boost stem cell harvest for myeloma patients
Disease control CompletedThis is a randomized, open-label study. Patients will be screened within 28 days prior to the study drug administration. Patients will be randomly assigned to 1 of 2 treatment arms prior to study drug administration. Approximately 40 patients will be randomized in a 1:1 ratio to…
Phase: PHASE2 • Sponsor: GPCR Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New hope for tough lymphoma: experimental drug JS203 enters human testing
Disease control OngoingThis is an open phase I clinical study to evaluate the safety, tolerability, pharmacokinetic (PK) profile, pharmacodynamic (PD) profile, immunogenicity, and preliminary efficacy of JS203 in patients with relapsed/refractory B-cell non-Hodgkin's lymphoma. The study is divided into…
Phase: PHASE1 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Could a simple cup cut STIs and BV? new trial hopes so
Disease control OngoingHIV remains a global pandemic with 37 million infected. In western Kenya, 16% of women in the general population and 29% of the poorest women have HIV. The HIV and sexually transmitted infection (STI) epidemics overlap with broader reproductive health concerns. Menstrual hygiene …
Phase: PHASE2 • Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Knee gel injection eases arthritis pain in 387-Patient study
Symptom relief CompletedThis study is designed to evaluate the effects of intra-articular injections of polyacrylamide hydrogel (Arthrosamid®) in patients with knee osteoarthritis. A total of 387 patients (593 knees) were treated across three medical centers in Türkiye. The purpose of the study is to d…
Sponsor: Feza Korkusuz MD • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Can a sleep app help save teens from suicide?
Symptom relief CompletedThe purpose of this research study is to test a brief (6-session), empirically supported, and highly disseminable version of digital (i.e., smartphone or web-based) cognitive behavioral therapy for insomnia (dCBT-I), called SleepioTM, in suicidal adolescents with co-occurring ins…
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Could a vaccine made from your own tumor fight advanced cancer?
Disease control Recruiting nowPhase 1 trial to evaluate the feasibility of preparation, safety, tolerability and response to a personalised autologous tumour vaccine (ATV) formulated with Advax adjuvant when administered to patients with advanced solid cancers either as monotherapy or in combination with othe…
Phase: PHASE1 • Sponsor: Vaxine Pty Ltd • Aim: Disease control
Last updated Jun 26, 2026 18:10 UTC
-
Diabetes drug semaglutide takes on dieting in fatty liver showdown
Disease control Recruiting nowTo evaluate the effects of subcutaneous injection of semaglutide for 12 weeks on patients with type 2 diabetes mellitus (T2DM), compared with concurrent energy-restricted management, on glycemic control, weight loss, inflammatory markers, liver fat content, and other parameters. …
Phase: PHASE4 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Can cycling and counseling curb opioid cravings?
Symptom relief OngoingThis work will involve conducting a randomized trial that will evaluate preliminary efficacy of "assisted" rate cycling, voluntary rate cycling and psychotherapy for pain individually and in combination as adjunctive treatments on cravings (primary outcome) in adults with an opio…
Phase: NA • Sponsor: Case Western Reserve University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
AI trained on 10,000 patients to spot bowel diseases faster
Diagnosis Recruiting nowPatients participating to this study will provide images and videos of capsule endoscopy to train, tune and evaluate technological bricks of artificial intelligence solutions, in order to improve diagnostic performances of the procedure, while reducing reading time by physicians.
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
New eye injection targets two causes of vision loss in wet AMD
Disease control CompletedThe purpose of the Phase 1/2a study is comprised of single ascending-dose component (Part 1), multiple ascending-dose component (Part 2) and multiple-dose extension component (Part 3) to evaluate the safety, tolerability, pharmacokinetics, and efficacy of ASKG712 in patients with…
Phase: PHASE1, PHASE2 • Sponsor: Visara, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug cocktail shows promise in advanced lung cancer trial
Disease control CompletedThis is an open-label phase Ib/II clinical study to evaluate the safety, tolerability, pharmacokinetics and initial efficacy of JS004 injection combined with toripalimab and with or without standard chemotherapy in patients with advanced lung cancer
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Could a Parkinson's drug help treat a key symptom of depression?
Symptom relief CompletedThe heterogeneity of depression suggests that several different neurocircuits and pathophysiological mechanisms are involved. Anhedonia - the inability to experience pleasure from, or the lack of motivation to carry out, usually enjoyable activities - is a promising endophenotype…
Phase: PHASE3 • Sponsor: Region Skane • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC